The vaccine candidate has yet to finish clinical trails and no efficacy data is available, but Taiwan's health ministry said studies so far have shown that antibodies created by the shot have been "no worse than"those created by AstraZeneca's )

目前沒有已撰寫的回應，建議對其抱持健康的懷疑。